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ABSTRACT 1 
Introduction: Endurance races have been associated with a substantial amount of adverse effects which 2 
could lead to chronic disease and long-term performance impairment.  However, little is known about 3 
the holistic metabolic changes occurring within the serum metabolome of athletes after the completion 4 
of a marathon.   5 
Objectives: Considering this, the aim of this study was to better characterize the acute metabolic 6 
changes induced by a marathon. 7 
Methods: Using an untargeted two dimensional gas chromatography time-of-flight mass spectrometry 8 
metabolomics approach, pre- and post-marathon serum samples of 31 athletes were analyzed and 9 
compared to identify those metabolites varying the most after the marathon perturbation.   10 
Results: Principle component analysis of the comparative groups indicated natural differentiation due 11 
to variation in the total metabolite profiles.  Elevated concentrations of carbohydrates, fatty acids, 12 
tricarboxylic acid cycle intermediates, ketones and reduced concentrations of amino acids indicated a 13 
metabolic shift between various fuel substrate systems.  Additionally, elevated odd-chain fatty acids 14 
and α-hydroxy acids indicated the utilization of α-oxidation and autophagy as alternative energy-15 
producing mechanisms.  Adaptations in gut microbe-associated markers were also observed and 16 
correlated with the metabolic flexibility of the athlete.  17 
Conclusion: From these results it is evident that a marathon places immense strain on the energy-18 
producing pathways of the athlete, leading to extensive protein degradation, oxidative stress, 19 
mammalian target of rapamycin complex 1 inhibition and autophagy.  A better understanding of this 20 
metabolic shift could provide new insights for optimizing athletic performance, developing more 21 
efficient nutrition regimens and identify strategies to improve recovery. 22 
Keywords: marathon; serum; metabolomics; metabolite markers; fuel substrates 23 
3 
1. INTRODUCTION 24 
Although physical activity has been shown to be substantially beneficial to human health (Ojiambo, 25 
2013), various negative effects including cardiovascular dysfunction (Webner et al., 2012), muscle 26 
damage (Howatson et al., 2010), increased propensity to upper respiratory tract infection (Robson-27 
Ansley et al., 2012) and severe inflammation (Bonasia et al., 2015) have been associated with running 28 
extensive distances, such as that of endurance races.  Even though these races have become increasingly 29 
popular, limited research is based on the elucidation of the effects of these races using a metabolomics 30 
approach.  Metabolomics is defined as the identification and quantification of the small metabolite 31 
compounds (<1500 Da) present in a biological system in order to determine the physiological effects 32 
induced by a specific perturbation (Heaney et al., 2017).  Since metabolites are typically the end-33 
products of the genome, transcriptome and proteome, alterations in these are indicative of the overall 34 
physiological state of the investigated biological system (Heaney et al., 2017). 35 
Previous metabolomics studies have indicated elevated concentrations of various 36 
carbohydrate/glycolysis metabolite intermediates, indicative of free glucose utilization as the preferred 37 
energy source during strenuous physical activity (Lewis et al., 2010; Salway, 2012; Waśkiewicz et al., 38 
2012).  Furthermore, significant alterations to the tricarboxylic acid cycle intermediates were induced 39 
by a marathon (Turer et al., 2014) and could be attributed to additional strain placed on the electron 40 
transport chain (ETC), causing an imbalanced NADH:NAD+ ratio (Esterhuizen et al., 2017).  According 41 
to previous work (Stellingwerff, 2012), free glucose and other carbohydrate stores can become depleted 42 
within approximately 90 min after the start of the race, which most likely lead to the utilization of 43 
alternative fuel substrates (lipids and amino acids) for energy production (Waśkiewicz et al., 2012).  44 
Increased lipolysis activity results in elevated serum glycerol and free fatty acids (Lewis et al., 2010; 45 
Waśkiewicz et al., 2012), the latter of which produce acetyl-CoA via β-oxidation and subsequent energy 46 
via the TCA cycle and ETC (Salway, 2012).  Furthermore, the increased synthesis of acetyl-CoA could 47 
also ascribe the elevated ketone concentrations previously reported (Pechlivanis et al., 2010), as it is a 48 
key component of ketogenesis.  In the event that the strenuous physical activity continues beyond the 49 
capacity of the athlete’s lipid stores, or if the traditional lipid oxidation pathways become saturated 50 
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(Staron et al., 1989), the athlete’s metabolism shifts towards protein catabolism (resulting in reduction 51 
blood amino acid levels) in an attempt to synthesize the energy required to complete the marathon 52 
(Lewis et al., 2010).  These amino acids are primarily oxidized to pyruvic acid and acetyl-CoA, both of 53 
which can serve as TCA cycle influx substrates for energy production (Salway, 2012).  Additionally, 54 
protein degradation has been shown to alter purine catabolism, resulting in elevated adenosine-55 
monophosphate, inosine-monophosphate, hypoxanthine, xanthine, uric acid and allantoin (Turer et al., 56 
2014), the latter of which is a uric acid derivative and a surrogate index of oxidative stress (Lewis et 57 
al., 2010). 58 
Although these metabolomics studies provide some clues to the metabolic alterations that occur during 59 
strenuous physical activity such as long-distance endurance races, very few of these employed an 60 
untargeted metabolomics approach.  Considering this, an untargeted two-dimensional gas 61 
chromatography time-of-flight mass spectrometry (GCxGC-TOFMS) metabolomics approach was used 62 
to holistically compare the serum metabolite profiles of 31 recreational marathon athletes before and 63 
after the completion of a marathon (42 km), in order to better characterize the acute metabolic changes 64 
induced by exercise stress.   65 
2. MATERIALS AND METHODS 66 
2.1 Participants  67 
All participants completed a health and dietary questionnaire (including a menstrual cycle questionnaire 68 
for female participants) prior to the marathon to assess their eligibility.  Individuals with food allergies, 69 
cardiovascular complications, musculoskeletal disorders/injuries, or those receiving anti-inflammatory 70 
treatment were excluded from the study.  Athlete participation in this investigation was completely 71 
voluntary, and all the participants gave written and informed consent.  A summary of the participant 72 
characteristics is presented in Table 1. 73 
2.2 Clinical samples 74 
5 
Blood samples were collected by antecubital fossa venesection of 31 marathon athletes (19 males and 75 
12 females) 24 hours before and immediately after completing the Druridge Bay Marathon 76 
(Northumberland, UK).  Pre-marathon samples were collected the day preceding the race (between 77 
10am and 6pm) as a means of reducing additional metabolic changes induced by the venesection stress 78 
as well as to limit interference to the athletes’ pre-marathon regimens.  The individuals were required 79 
to be in a hydrated, yet fasted state (for a minimum of two hours) at time of baseline sample venesection.  80 
The samples were collected in standard 10 mL vacutainer vials, placed on ice and transported to the 81 
laboratory (Faculty of Health and Life Sciences, Department of Sport, Exercise and Rehabilitation at 82 
the Northumbria University in Newcastle upon Tyne, UK) for immediate processing.  Briefly, the blood 83 
was allowed to clot for 30 min and centrifuged at 3 000 g for 10 min.  The supernatant (serum) was 84 
then extracted and immediately frozen (-80°C) before being transported (on dry ice) to the North-West 85 
University, Human Metabolomics: Laboratory of Infectious and Acquired Diseases.  These serum 86 
samples were stored at -80°C until metabolomics analyses commenced.   87 
2.3 Chemicals and reagents 88 
Methoxamine hydrochloride, 3-phenylbutyric acid and bis(trimethylsilyl)-trifluoroacetamide (BSTFA) 89 
with 1% trimethylchlorosilane (TMCS) were purchased from Sigma Aldrich (St. Louis, Missouri, USA) 90 
and the pyridine was from Merck (Darmstadt, Germany).  The acetonitrile used, was an ultra-pure 91 
Burdick and Jackson brand (Honeywell International Inc., Muskegon, Michigan, USA) and hence did 92 
not require any further purification. 93 
2.4 Sample extraction and derivatization 94 
A total metabolome extraction procedure was performed on all the collected serum samples, along with 95 
appropriate quality control (QC) samples.  During this process 50 μL of internal standard,  96 
3-phenylbutyric acid (0.45 μg/mL) dissolved in a chloroform:methanol:water (1:3:1) solution, was 97 
added to 50 μL of each serum sample.  Hereafter, the samples were placed on ice before 300 μL of 98 
acetonitrile was added as a protein precipitation agent.  Samples were then subjected to the REAX D-99 
91126 vortex (Heidolph Instruments GmbH & Co.KG, Schwabach, Germany) for 2 min and centrifuged 100 
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at 3 500 g for 10 min at 4°C.  The supernatant of the biphasic solution was then transferred to a clean 101 
GC-MS sample vile and dried at 40ºC under a light stream of nitrogen gas for approximately 45 min.  102 
Hereafter, 25 μL of methoxamine hydrochloride dissolved in pyridine (15 mg/mL) was added to each 103 
sample and incubated at 50°C for 90 min.  Thereafter, 40 μL BSTFA with 1% TMCS was added, 104 
followed by derivatization for 60 min at 60°C.  Each derivatized sample was transferred to a new GC-105 
MS vile containing a vile insert and capped. 106 
2.5 GCxGC-TOFMS analysis and processing 107 
The derivatized samples were placed on a multi-purpose auto-sampler tray (Gerstel GmbH and co. KG, 108 
Mülheim van der Ruhr, Germany) in a randomized order, and analyzed using a Pegasus 4D GCxGC-109 
TOFMS system (LECO Africa (Pty) Ltd, Johannesburg, South Africa), fitted with an Agilent 7890A 110 
GC and TOFMS (LECO Africa).  During analyses, 1 μL of each sample was injected using a 1:3 split 111 
ratio.  Purified helium was used as a carrier gas and set at a constant flow rate of 1 mL/min, while the 112 
injector temperature was set to operate at a constant 270°C throughout the entire sample analysis.  The 113 
primary oven was fitted with a Restek Rxi-5MS capillary column (30 m; 0.25 µm diameter and 0.25 µm 114 
film thickness) and programmed to start the run at an initial temperature of 70°C for 2 min, followed 115 
by an increase of 4°C/min until a final temperature of 300°C was reached and maintained for 2 min.  116 
The secondary oven, equipped with a Restek Rxi-17 capillary column (1 m; 0.25 µm diameter and 117 
0.25 µm film thickness), was programmed with an initial 85°C, which was increased by 4.5°C/min until 118 
a final temperature of 300°C was reached and maintained for 2 min.  The thermal modulator was set to 119 
pulse streams of cold and hot nitrogen gas every 3 s, for 0.5 s.  The detector was set to disregard all 120 
mass spectra (ms) information for the first 400 s of each run to exclude solvent detection; however, this 121 
was still included on the time axis of the primary column to reflect accurate retention times.  122 
Additionally, the transfer line and ion source were respectively held at a constant of 270°C and 220°C 123 
for the entire run, with a detector voltage of 1600 V and filament bias of -70 eV.  Ms were acquired at 124 
a rate of 200 ms per second, over a range of 50–800 m/z.  The total run time per sample was 111.28 125 
min.  Following GCxGC-TOFMS analysis, 838 peaks were identified, which was processed using 126 
LECO Corporation’s ChromaTOF software (version 4.32), as described by (Luies and Loots, 2016). 127 
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2.6 Statistical analyses 128 
Prior to statistical analysis, the data were normalized in relation to the internal standard and subjected 129 
to several “clean-up steps”, including a 50% zero filter, QC drift correction, QC coefficient of variation 130 
filter and zero value replacement (Fernandez et al., 2000; Luies and Loots, 2016).  Hereafter, a natural 131 
shifted log transformation was performed to correct for skewed variable distribution, as well as auto 132 
scaling to align all variables (Van den Berg et al., 2006) (exclusively during multivariate analysis). 133 
Both multivariate and univariate statistical analyses were performed using MATLAB software (2012), 134 
adjusted with the PLS toolbox (2016), to identify the metabolite markers best describing the variation 135 
between the comparative groups.  Multivariate approaches included principle component analysis 136 
(PCA) to determine whether a natural differentiation occurred between the comparative groups, and 137 
partial least square–discriminant analysis (PLS-DA) to characterize the group separation (Luies and 138 
Loots, 2016).  The univariate data analyses included a Wilcoxon signed rank test, corrected for multiple 139 
testing by the Benjamini–Hochberg procedure, to assess the statistical significance of each compound 140 
(Benjamini and Hochberg, 1995; Rosner et al., 2006), while an independent effect size calculation 141 
(Wilcoxon signed effect size) was used to assess the practical significance of each detected metabolite 142 
(Tomczak and Tomczak, 2014). 143 
3. RESULTS  144 
The PCA differentiation between serum metabolite profiles (Fig. 1) of the marathon athletes before and 145 
after the completion marathon was clearly defined.  The total amount of variance explained by the first 146 
three principle components (PCs) (R2X cum) was 53%, of which PC1 accounted for 24%, PC2 for 20% 147 
and PC3 for 9%.  Additionally, the PLS-DA model (results not shown) showed a modelling parameter 148 
R2Y (cum) of 48.81%, indicating the total variance of the response Y, and a Q2 (cum) of 83.37%, 149 
indicating the cross-validation variation due to the response Y. 150 
Since the aim of this study was to attain a holistic view of the altered human serum metabolome induced 151 
by a marathon, compounds with a PCA power value ≥ 0.5 or Wilcoxon p-value ≤ 0.017 (BH-critical 152 
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value) or an effect size ω-value ≥ 0.3 were considered significant and interpreted based on their 153 
associated metabolic/biochemical pathways.  This multi-statistical approach yielded an initial list of 78 154 
metabolite markers, of which 70 metabolite markers could be annotated by comparison of their mass 155 
spectra and retention times to that of commercially available and in-house libraries developed from 156 
previously injected standards (see Table 2).  157 
4. DISCUSSION 158 
The altered metabolite markers listed in Table 2 are indicative of the major metabolic pathways affected 159 
by the marathon and are mainly associated with the macro-fuel substrate utilization pathways 160 
(carbohydrates, lipids and amino acids) and the regulation thereof (TCA, oxidative phosphorylation 161 
[OXPHOS] and gut microbiome).  These metabolite pathways, along with the intermittent dietary-162 
associated metabolite markers, are comprehensively discussed below and schematically presented in 163 
Fig. 2.  164 
Various carbohydrate metabolites were significantly elevated following the marathon and can be 165 
ascribed to gluconeogenic influx (MacLaren and Morton, 2012) and a reduced insulin secretion (Richter 166 
et al., 1992), which is typically induced by an initial depletion of glucose and glycogen stores occurring 167 
approximately 90 min after the start of a marathon (exercise intensity dependent) at a VO2max >75% 168 
(Stellingwerff, 2012).  The reduced insulin concentrations temporarily inactivate insulin-dependent 169 
glucose uptake systems (i.e. GLUT 4 transporters and glucokinase) (Salway, 2012), preventing glucose 170 
absorption into cells.  This could ascribe the post-marathon elevations in serum glucose concentrations 171 
and various other associated metabolites, including glucaric acid (Żółtaszek et al., 2008) and mannose 172 
(Hu et al., 2016) as well as the elevated concentrations of gluconeogenesis-associated metabolites, i.e. 173 
myo-inositol (Eisenberg and Parthasarathy, 1987), erythritol (synthesized via erythrose-4-phosphate in 174 
pentose pathway) (Hootman et al., 2017), glycerol and glyceric acid (Salway, 2012; Wadman et al., 175 
1976).  Furthermore, the elevated concentrations of pyruvic acid observed in the post-marathon samples 176 
were anticipated since it is an end-product of the glycolysis pathway which feeds into the TCA cycle 177 
for further ATP production (Salway, 2012).  This is confirmed by the accumulation of various TCA 178 
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cycle intermediates such as α-ketoglutaric acid, succinic acid, citric acid, fumaric acid and malic acid 179 
(Qiang, 2015), which also indicate the accumulation of circulating NADH/FADH2 molecules 180 
(Esterhuizen et al., 2017) as a result of a saturated ETC activity.  It is also important to mention that 181 
many of the aforementioned carbohydrate metabolites, along with elevated concentrations of mannose 182 
(Hu et al., 2016), sorbose (Guzik and Stachowicz, 2016), mannitol (McNutt, 2000), tagatofuranose 183 
(Kroger et al., 2006), and threonic acid (an ascorbic acid derivative) (Simpson and Ortwerth, 2000), are 184 
well-known constituents of fruits/fruit juices, vegetables/vegetable juices, peanuts, energy bars, energy 185 
drinks and various other ergogenic aids consumed by the athletes during the course of the marathon 186 
(Jeukendrup, 2011; Pfeiffer et al., 2012). 187 
The reduction in intracellular glucose due to the aforementioned cellular uptake inhibition is known to 188 
activate lipolysis of free and adipose tissue-bound triacylglycerol (TAG) (MacLaren and Morton, 2012) 189 
as alternative fuel substrates.  This is substantiated by the elevated concentrations of serum glycerol, 190 
monopalmitin and various free fatty acids (lauric acid, palmitic acid, palmitoleic acid, 11-eicosenoic 191 
acid, 11,14-eicosadienoic acid, myristoleic acid, α-linolenic acid, 5-dodecenoic acid, linoleic acid and 192 
oleic acid) (Kujala et al., 2013; Lewis et al., 2010; Peake et al., 2014; Waśkiewicz et al., 2012).  193 
Additionally, accumulated 3-hydroxy acids (β-hydroxyhexanoic acid) and 3-keto acids  194 
(β-hydroxy-α,β-didehydrosebacic acid) are indications of a saturated β-oxidation pathway, ascribed to 195 
the inhibition of the rate-limiting enzyme, β-hydroxyacyl dehydrogenase, which is pursued by  196 
3-ketoacyl-CoA thiolase.  This saturated β-oxidation pathway results in the catabolism of the 197 
accumulated fatty acids via α-oxidation (Roe and Ding, s.a.), thus substantiating the elevated 198 
concentrations of α-hydroxyoctanoic acid (C8; an α-oxidation intermediate) and the odd-chain fatty 199 
acids (OCFA; tridecanoic acid [C13], pentadecanoic acid [C15], heptadecanoic acid [C17] and  200 
10-heptadecenoic acid [C17:1]) detected in the post-marathon serum.  It should however be mentioned 201 
that these OCFA may also arise from elevated dietary intake (Jenkins et al., 2017) and/or autophagy of 202 
various cellular constituents during extensive energy-requiring states (Singh and Cuervo, 2011).  203 
Nevertheless, irrespective of their origins, these OCFAs are ultimately catabolized to propionyl-CoA 204 
(Pfeuffer and Jaudszus, 2016), hence the elevated β-hydroxypropionic acid observed in the post-205 
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marathon serum.  The elevated concentrations of β-hydroxybutyric acid and acetoacetic acid are 206 
anticipated, as these are alternative fuel substrates for the brain (Cahill and Vech, 2003) and skeletal 207 
muscles (Holloszy and Coyle, 1984) in hypoglycemic states, and could also be an indication of an 208 
imbalanced redox state (Esterhuizen et al., 2017; Salway, 2012).  Furthermore, the post-marathon 209 
elevations of malonic acid typically indicate the accumulation of malonyl-CoA, which is a long-chain 210 
fatty acid (LCFA) transport inhibitor (Salway, 2012) and could therefore be an additional reason for the 211 
increased cytosolic LCFAs (palmitic acid, palmitoleic acid, 11-eicosenoic acid, 11,14-eicosadienoic 212 
acid, myristoleic acid, α-linolenic acid, linoleic acid and oleic acid).   213 
Most amino acids are catabolized into TCA cycle substrates via propionyl-CoA, succinyl-CoA, pyruvic 214 
acid or acetyl-CoA, depending on the specific amino acid (Salway, 2012).  Reduced concentrations of 215 
amino acids (serine, glycine, alanine, aspartic acid, phenylalanine, tyrosine, threonine and methionine) 216 
and altered amino acid-associated metabolite concentrations (dimethylglycine (Holm et al., 2003), 217 
pyroglutamic acid (Kumar and Bachhawat, 2012), indole-3-acetic acid (Salway, 2012) and glutaric acid 218 
(Peake, 2016)) were detected in the post-marathon serum, which indicates amino acid catabolism during 219 
the marathon.  Furthermore, elevated concentrations of α-hydroxybutyric acid (an intermediate in the 220 
threonine/methionine pathway), further supports the aforementioned NADH:NAD+ imbalance, 221 
ketoacidosis, reduced insulin secretion and impaired glucose absorption (Gall et al., 2010).  222 
Additionally, elevated p-hydroxyphenylacetic acid and  223 
p-hydroxyphenyllactic acid could be indicative of mild liver injury/damage (Ghoraba et al., 2014; 224 
Liebich and Pickert, 1985), which concur with previous findings (Jastrzebski et al., 2015; Lippi et al., 225 
2011). 226 
In accordance with previous findings (Pechlivanis et al., 2010), reduced serum concentrations of the 227 
branched-chain amino acids (BCAAs) isoleucine (0.05 vs 0.02 µg/mL, p=0.018), valine and leucine 228 
were detected in the post-marathon samples, while their catabolism intermediates i.e.  229 
α-ketoisovaleric acid, β-hydroxyisobutyric acid (valine metabolites) and α-ethylhyrdracrylic acid (allo-230 
isoleucine metabolism) (Wendel et al., 1989) were significantly elevated.  Allo-isoleucine catabolism 231 
intermediates may serve as alternative substrates in the valine catabolism pathway (Ryan, 2015), 232 
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however, since the valine catabolism intermediates remained elevated in the post-marathon serum it can 233 
be deducted that allo-isoleucine is instead catabolized to α-ethylhydracrylic acid (Korman et al., 2005) 234 
via α-keto-β-methylvaleric acid (explaining its reduced concentrations post-marathon) with the 235 
subsequent production of FADH2 (Korman et al., 2005).  The elevated concentrations of β-236 
hydroxyisovaleric acid detected post-marathon is typically associated with ketone rich environments 237 
(as observed in the current investigation), resulting from increased leucine catabolism and the 238 
subsequent isovaleryl-CoA production (Mock et al., 2011).  This metabolite is also a well-known 239 
constituent of athlete supplementation (Brioche et al., 2016) and could be elevated due to dietary 240 
ingestion during the marathon.  Furthermore, reduced concentrations of these BCAAs, in particular 241 
leucine, results in mammalian target of rapamycin complex 1 inhibition (Laplante and Sabatini, 2009), 242 
which in turn activates various catabolic processes such as autophagy (of organelle and plasma 243 
membrane constituents) to release additional embedded fuel substrates (Singh and Cuervo, 2011).  244 
Mammalian target of rapamycin complex 1 (mTOR1) inhibition can also be induced by other factors 245 
including elevated 5'-AMP-activated protein kinase during energy deprivation, reduced oxygen levels, 246 
reduced essential amino acids and inflammation (Laplante and Sabatini, 2009), all of which are 247 
associated with endurance races and evidently occur in the marathon athletes investigated in this study.  248 
Considering that autophagy contributes to elevated amounts of cellular debris, the aforementioned 249 
accumulation of fatty acids and especially the OCFAs, in the post-marathon serum may also be 250 
explained by the autophagosomal degradation of phospholipids, sphingolipids (Kishimoto et al., 1973; 251 
Maes et al., 1996) and phytosphingosines (Kitamura et al., 2017; Kondo et al., 2014) found in cell and 252 
organelle membranes.  Additionally, the elevated concentrations of squalene and 5-pregnene-3β,20α-253 
diol in the post-marathon serum suggest cholesterol degradation (Charlton-Menys and Durrington, 254 
2007; Salway, 2012), further supporting the activation of autophagy as the latter is a common 255 
constituent in cell membranes (Salway, 2012).  Elevated 5-pregnene-3β,20α-diol (also known as 20α-256 
dihydropregnenolone) post-marathon also indicates steroid metabolism activation via cholesterol 257 
catabolism as it is produced by the reduction of pregnenolone via 20-hydroxysteroid dehydrogenase 258 
(Ebner et al., 2006).  Pregnenolone is a precursor for the production of aldosterone and cortisol, the 259 
latter of which stimulates lipolysis, gluconeogenesis and protein catabolism (Salway, 2012).   260 
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Furthermore, a significant decrease in α-aminomalonic acid concentrations was observed in the post-261 
marathon serum samples.  Although the precise origin of this metabolite is unknown, it has been 262 
associated with abnormal protein oxidation, macrophage accumulation, non-essential amino acid 263 
oxidation via reactive oxygen species and pulmonary arterial hypertension indication (Bujak et al., 264 
2016). 265 
The microbiome plays a crucial role in many essential metabolic processes required during strenuous 266 
exercise, including the regulation of energy metabolism, oxidative stress and inflammatory response 267 
pathways (Mach and Fuster-Botella, 2017).  To this end, various microbial-associated metabolites (i.e. 268 
tagatofuranose, talofuranose, ethyl-α-D-glucopyranoside, arabitol, indole-3-propionic acid and  269 
D-rhamnose) were significantly altered in the post-marathon samples.  Most of these metabolites are 270 
synthesized from host carbohydrate intermediates, either via catabolism or fermentation processes 271 
(arabitol: a sugar alcohol produced form arabinose/glucose (Kumdam et al., 2014); and ethyl-α-D-272 
glucopyranoside: an ethnolysis product from glucose (Hu et al., 2013)).  Indole-3-propionic acid is the 273 
deamination product of tryptophan, produced by gut microbes (e.g. Clostridium sporogenes) (Wikoff 274 
et al., 2009) and further supports the notion of reduced amino acids.  The reduced concentrations of D-275 
rhamnose, a component of most Gram-positive bacterial cell walls (Mistou et al., 2016), contradict the 276 
above-mentioned microbial product elevations.  Since the particular nature of this reduction following 277 
completion of the marathon is unclear, it warrants future investigation.  278 
In addition to these endogenously and microbially produced metabolites, elevated concentrations of 279 
ibuprofen were also observed post-marathon.  Ibuprofen is a well-known non-steroidal, anti-280 
inflammatory drug (Nieman et al., 2006) commonly used by athletes for preventing muscle damage, 281 
muscle soreness and inflammation and was most likely consumed by some athletes prior to/during the 282 
marathon (Mcanulty et al., 2007). 283 
5. CONCLUSION 284 
The results of this metabolomics investigation suggest that the body utilizes various fuel substrate 285 
pathways to comply with the high energy demands required during the marathon, including catabolism 286 
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of carbohydrates, lipids (β-oxidation and α-oxidation) and amino acids, as well as activation of 287 
ketogenesis and autophagy via mTOR1 inhibition.  Considering the results of the current investigation 288 
as well as previous literature, the possible cascade of events contributing to this metabolic “snapshot” 289 
could be summarized as follows: (a) A proposed initial reduction in carbohydrate catabolism and 290 
glucose uptake via the insulin-dependent transporters lead to glycolysis dysregulation, ketogenesis 291 
activation and increased serum glucose.  (b) A metabolic shift towards fatty acid utilization (from either 292 
endogenous or dietary TAGs) is induced, which (c) overwhelms/saturates the β-oxidation pathway, 293 
resulting in the α-oxidation of fatty acids.  (d) Amino acids (from either endogenous or dietary protein 294 
catabolism) are also used as alternative fuel substrates, resulting in (e) mTOR1 inhibition and autophagy 295 
as the body desperately tries to generate the necessary fuel substrates to comply with the energy demand.  296 
(f) Lastly, various metabolic processes are activated to reduce oxidative stress and regulate/correct the 297 
redox imbalance.   298 
Possible limitations of this study include human genotype/phenotype variation (an inevitable 299 
confounder) and the uncontrolled dietary intake of the athletes during the marathon.  However, 300 
convincing athletes to deviate from their individualized supplementation protocols would be extremely 301 
difficult, if not impossible.  Validation using a larger sample cohort could further substantiate the current 302 
findings.  Nonetheless, these findings indicate the extensive metabolic changes induced by the marathon 303 
perturbation.  Possible future prospects could be to investigate the effects of supplementing with amino 304 
acids, pre- and probiotics, and β-hydroxyisovaleric acid as a means of improving aerobic exercise 305 
performance, reduce skeletal muscle and liver damage, and enhance recovery. 306 
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9. TABLES 510 
Table 1 Summary of the participant demographical information 511 
Participant demographical information 
Average ± Standard 
deviation 
Age (years) 41 ± 12 
Pre-marathon athlete weight (kg) 71.3 ± 10.1 
Post-marathon athlete weight (kg) 69.2 ± 9.7 
Marathon experience (years) 9 ± 8 
Marathon experience (races) 16 ± 29 
Finishing time (hh:mm:ss) 04:19:09 ± 00:49:01 
 512 
Table 2 The significant serum metabolite markers best describing the variation between the pre- and 513 
post-marathon groups, listed alphabetically 514 
Metabolite name  
(PubChem ID) 
Pre-marathon 
athletes: 
Post-marathon 
athletes: 
Wilcoxon Signed 
Rank test 
PCA 
Concentration (µg/ml) (Standard 
deviation) 
(p 
value) 
(ω 
value) 
(Power
) 
α-Aminomalonic acid (100714) 0.046 (0.022) 0.025 (0.009) 3.1x10-4 0.458 0.031 
α-Ethylhydracrylic acid (188979) 0.002 (0.001) 0.005 (0.002) 1.3x10-6 0.615 0.025 
α-Hydroxybutyric acid (11266) 0.019 (0.011) 0.045 (0.023) 2.8x10-6 0.595 0.018 
α-Hydroxyoctanoic acid (94180) 8.7x10-5 (5.3x10-5) 1.2x10-4 (6.3x10-5) 0.001 0.413 0.003 
α-Ketoglutaric acid (51) 2.9x10-4 (2.1x10-4) 4.5x10-4 (1.8x10-4) 1.1x10-4 0.490 0.009 
α-Ketoisovaleric acid (5204641) 0.002 (0.001) 0.003 (0.001) 1.7x10-4 0.478 0.017 
α-Keto-β-methylvaleric acid (47) 0.009 (0.003) 0.007 (0.002) 0.005 0.358 0.025 
α-Linolenic acid (5280934) 1.6x10-4 (8.1x10-5) 4.5x10-4 (2.6x10-4) 2.1x10-6 0.602 0.021 
β-Hydroxybutyric acid (441) 0.021 (0.019) 0.215 (0.161) 1.2x10-6 0.617 0.030 
β-Hydroxyhexanoic acid (151492) 3.2x10-4 (1.6x10-5) 8.9x10-4 (3.1x10-4) 2.1x10-6 0.602 0.033 
β-Hydroxyisobutyric acid (87) 2.9x10-5 (4.9x10-5) 2.9x10-4 (1.4x10-4) 1.2x10-6 0.617 0.034 
β-Hydroxyisovaleric acid (69362) 0.002 (0.001) 0.002 (0.001) 0.011 0.321 0.009 
22 
β-Hydroxypropionic acid (68152) 0.003 (0.001) 0.004 (0.001) 0.007 0.343 0.013 
β-Hydroxy-α,β-didehydrosebacic 
acid (5366445) 
0.005 (0.002) 0.006 (0.002) 0.009 0.333 0.013 
5-Dodecenoic acid (5312377) 1.3x10-4 (2.8x10-5) 0.002 (0.001) 1.2x10-6 0.617 0.037 
5-Pregnene-3β,20α-diol 
(312224064) 
3.0x10-4 (2.7x10-4) 6.1x10-4 (4.3x10-4) 3.4x10-6 0.590 0.007 
10-Heptadecenoic acid 
(86289714) 
0.001 (0.001) 0.003 (0.001) 1.2x10-6 0.617 0.030 
11-Eicosenoic acid (142770) 0.001 (0.001) 0.004 (0.001) 1.3x10-6 0.615 0.033 
11,14-Eicosadienoic acid (3208) 0.002 (0.001) 0.003 (0.001) 9.3x10-4 0.421 0.008 
Acetoacetic acid (96) 7.5x10-5 (5.4x10-5) 2.1x10-4 (1.5x10-4) 0.002 0.393 0.014 
Alanine (5950) 4.2x10-4 (2.9x10-4) 2.6x10-4 (1.5x10-4) 0.004 0.368 0.003 
Arabitol (439255) 0.004 (0.001) 0.005 (0.002) 9.9x10-4 0.418 0.006 
Aspartic acid (5960) 0.020 (0.012) 0.013 (0.007) 0.014 0.311 0.019 
Citric acid (311) 9.6x10-4 (4.5x10-4) 0.002 (0.001) 8.9x10-5 0.498 0.012 
Dimethylglycine (673) 0.023 (0.013) 0.017 (0.008) 0.011 0.324 0.008 
D-Rhamnose (5460029) 0.001 (0.001) 0.001 (0.001) 1.1x10-2 0.324 0.006 
Erythritol (222285) 0.007 (0.002) 0.012 (0.004) 1.6x10-6 0.610 0.016 
Ethyl-α-D-glucopyranoside 
(91733361) 
0.169 (0.085) 0.213 (0.094) 0.008 0.336 0.003 
Fumaric acid (444972) 0.005 (0.002) 0.007 (0.002) 7.5x10-4 0.428 0.018 
Glucaric acid (33037) 4.1x10-4 (1.8x10-4) 0.001 (0.001) 0.002 0.391 0.010 
Glucose (5793) 0.001 (0.001) 0.003 (0.005) 8.7x10-6 0.565 0.025 
Glutaric acid (743) 3.1x10-4 (1.9x10-4) 4.7x10-4 (2.8x10-4) 0.009 0.331 0.009 
Glyceric acid (752) 0.005 (0.002) 0.008 (0.003) 6.9x10-5 0.505 0.015 
Glycerol (753) 0.088 (0.042) 0.447 (0.143) 1.2x10-6 0.617 0.041 
Glycine (750) 0.042 (0.019) 0.026 (0.013) 7.5x10-4 0.428 0.024 
Heptadecanoic acid (10465) 0.004 (0.001) 0.006 (0.001) 1.2x10-6 0.617 0.020 
Ibuprofen (3672) 7.5x10-6 (1.8x10-5) 0.004 (0.013) 6.4x10-5 0.508 0.011 
Indole-3-propionic acid (3744) 0.002 (0.001) 0.001 (0.001) 1.8x10-4 0.475 0.004 
Indole-3-acetic acid (802) 0.003 (0.002) 0.002 (0.001) 8.1x10-4 0.426 0.021 
Lauric acid (3893) 0.011 (0.003) 0.020 (0.005) 1.2x10-6 0.617 0.026 
23 
Leucine (6106) 0.130 (0.087) 0.064 (0.044) 0.002 0.398 0.022 
Linoleic acid (5280450) 0.124 (0.050) 0.168 (0.055) 4.9x10-4 0.443 0.006 
Malic acid (525) 0.004 (0.002) 0.007 (0.003) 3.1x10-6 0.592 0.018 
Malonic acid (867) 3.1x10-4 (1.2x10-4) 4.1x10-4 (1.7x10-4) 0.005 0.353 0.006 
Mannitol (6251) 0.004 (0.004) 0.007 (0.010) 0.006 0.348 0.004 
Mannose (18950) 3.2x10-4 (4.3x10-4) 0.003 (0.005) 5.5x10-6 0.577 0.024 
Methionine (6137) 0.006 (0.004) 0.003 (0.002) 6.9x10-4 0.431 0.017 
Myo-inositol (892) 0.031 (0.030) 0.045 (0.035) 8.1x10-4 0.426 0.011 
Monopalmitin (14900) 3.9x10-4 (2.1x10-4) 6.7x10-4 (3.6x10-4) 0.002 0.401 0.011 
Myristoleic acid (5281119) 0.001 (0.001) 0.006 (0.002) 1.2x10-6 0.617 0.037 
Oleic acid (445639) 0.127 (0.072) 0.511 (0.196) 1.3x10-6 0.615 0.022 
Palmitic acid (985) 0.423 (0.124) 0.633 (0.128) 1.6x10-5 0.548 0.016 
Palmitoleic acid (445638) 0.009 (0.008) 0.042 (0.022) 7.2x10-6 0.570 0.026 
Pentadecanoic acid (13849) 0.004 (0.002) 0.008 (0.002) 1.2x10-6 0.617 0.022 
Phenylalanine (6140) 0.030 (0.015) 0.020 (0.009) 0.002 0.393 0.021 
p-Hydroxyphenylacetic acid (127) 0.002 (0.001) 0.003 (0.002) 0.001 0.408 0.008 
p-Hydroxyphenyllactic acid 
(9378) 
0.003 (0.002) 0.005 (0.002) 2.9x10-4 0.460 0.014 
Pyroglutamic acid (7405) 0.060 (0.014) 0.050 (0.023) 2.3x10-4 0.468 0.009 
Pyruvic acid (1060) 0.013 (0.009) 0.024 (0.012) 7.5x10-4 0.428 0.016 
Serine (5951) 0.033 (0.024) 0.018 (0.011) 0.014 0.314 0.021 
Sorbose (439192) 0.015 (0.006) 0.022(0.01) 6.1 x10-4 0.436 0.008 
Squalene (638072) 0.002 (0.001) 0.003 (0.004) 0.006 0.351 0.011 
Succinic acid (1110) 0.011 (0.008) 0.016 (0.010) 5.5x10-6 0.577 0.006 
Tagatofuranose (12306016) 0.101 (0.058) 0.190 (0.122) 3.9x10-4 0.450 0.012 
Talofuranose (15560229) 0.147 (0.050) 0.253 (0.090) 2.3x10-5 0.538 0.011 
Threonic acid (5460407) 0.011 (0.004) 0.016 (0.005) 1.1x10-5 0.557 0.025 
Threonine (6288) 0.021 (0.014) 0.011 (0.007) 0.003 0.381 0.017 
Tridecanoic acid (12530) 2.4x10-4 (1.0x10-4) 3.8x10-4 (1.7x10-4) 9.5x10-6 0.562 0.010 
Tyrosine (6057) 0.019 (0.008) 0.014 (0.006) 0.007 0.343 0.018 
Valine (6287) 0.188 (0.115) 0.094 (0.061) 9.3x10-4 0.421 0.027 
Abbreviations: PCA: Principle component analysis 515 
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 516 
10. FIGURE LEDGENDS 517 
Fig. 1 Principle component analysis scores plot showing clear differentiation of the serum samples of 518 
marathon athletes before (denoted by circles) and after (denoted by squares) the completion of a 519 
marathon.  The variance accounted for are indicated in parenthesis.  Abbreviations: PC: principle 520 
component521 
 522 
  523 
25 
Fig. 2 A schematic representation of the altered serum metabolome induced by a marathon.  The altered 524 
metabolites are either donated as increased (↑) or decreased (↓) relative to the pre-marathon group.  525 
Abbreviations: FAD: flavin adenine dinucleotide, FADH: flavin adenine dinucleotide + hydrogen, 526 
NAD: nicotinamide adenine dinucleotide, NADH: nicotinamide adenine dinucleotide + hydrogen, 527 
ATP: adenosine triphosphate, ADP: adenosine diphosphate 528 
 529 
